Stem Cell research and therapy have been growing at a rapid rate over the past fifteen years. Scientific advances coupled with consumer demand have proven that stem cell therapy is the wave of the future, and is poised to change the face of medicine.
The only hurdles have been religious and regulatory roadblocks slowing down the approval process for fetal stem cell therapy, arguably the most contested and controversial form of stem cell therapy to date, due to them being harvested from abortions.
The God Cells takes the audience on a journey with those who seek the life changing fetal stem cell therapy abroad, while avoiding the seemingly insurmountable roadblocks at home.
“The demand is real, patients with current unmet medical needs are desperate and require this therapy, but the current regulatory and industry hurdles are making it near impossible for us to do our job and get these important stem cell therapies to those people in need. Because of this, many scientific organizations are taking their technology abroad to appease patient demand, because they feel the current regulatory hurdles are insurmountable.”
Randal Mills, PhD, President and CEO for California Institute For Regenerative Medicine
Burzynski: The Cancer Cure Cover-up is the story of a pioneering biochemist who discovered a unique and proprietary method of successfully treating most cancers. This documentary takes the audience on a near 50-year journey both Dr. Burzynski and his patients have been enduring in order to obtain FDA-approved clinical trials of Antineoplastons. Defying the face of skepticism, legal attacks from state and federal agencies, and a powerful propaganda campaign to stop Burzynski – this doctor and his patients are still going strong.
Due to the continued failed efforts of state and federal agencies in their attempts to stop Burzynski from continuing to treat patients and expand his research, special interest groups have since launched a relentless propaganda campaign against Dr. Burzynski, and his supporters and patients, in hopes that this game-changing innovation never reach the open market.
The primary reason that the cancer industry and its regulatory agencies fear the approval of Antineoplastons is purely economical.
If Antineoplastons were FDA-approved for just one cancer type this would mean that anyone of any age diagnosed with any type of cancer could legally insist their oncologist provide them with Antineoplastons “off-label”. Given the gentle and nontoxic nature of these medications, most people would begin to opt for Antineoplastons as a first line of defense against their cancer instead of first choosing life-threatening yet profitable chemotherapy and radiation.
Burzynski: The Cancer Cure Cover-up investigates this hidden cancer treatment and the decades of failed lawsuits the US government and FDA have pursued in order to try to silence him.